The Lateral Flow Assays Market is anticipated to be valued at US$ 4.3 billion in 2023, growing to US$ 6.9 billion by 2033. During the forecast period, lateral flow assay sales are expected to expand at a CAGR of 4.7%. The market profited from the COVID-19 pandemic. The use of lateral flow test kits, which …
Category Archives: Healthcare Trends
Mammalian Transient Protein Expression Market is anticipated to exceed US$ 1581.6 million by 2033 | FMI
As per the latest market research conducted by FMI, the global Mammalian Transient Protein Expression Market is likely to record a CAGR of 8.5% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 697.2 million. By 2033, the valuation is expected to reach US$ 1,581.6 million. The …
India Coronary Stent Market is estimated to cross US$ 4.45 Billion at a CAGR of 14% by 2032 | FMI Study
The Indian coronary stent market is expected to exceed US$ 4.45 billion by 2032. by Future Market Insights (FMI). Over the course of the forecast period, the market is anticipated to experience a CAGR of 14.0% in terms of value. This study illustrates market dynamics and trends that will affect the coronary stents market in India over …
The North American Over-the-Counter Pain Medication Market accounts for 33.4% of the global total | FMI Report
Over-the-Counter Pain Medication Market is expected to reach a valuation of US$ 27.7 Billion by the end of 2028, up from their present global revenue of US$ 21.8 Billion in 2022. From 2022 to 2028, the demand for over-the-counter painkillers is anticipated to grow at a CAGR of 4.1%. Many consumers are making a shift …
The highest revenue share of the Flow Cytometry Market comes from the United States | Says FMI Analyst
The Global Flow Cytometry Market is estimated to have profitable growth at a 7.4% CAGR from 2022 to 2032. The global market is expected to reach a valuation of US$ 5.6 billion by the end of 2022 and almost US$ 11.4 billion by the end of 2032. According to Future Market Insights studies on the …
Renal Biomarker Market is expected to touch a valuation of US$ 2.6 Billion by 2032 | FMI
Renal Biomarker Market is anticipated to experience a 7.0% year-over-year growth in demand, reaching US$ 2.6 billion in 2032. According to Future Market Insights analysts, a rising prevalence of renal diseases is likely to boost the growth of the global renal biomarker market over the forecast period. Other prominent growth factors include a large number …
Medical Biomimetics Market value of US$ 32.10 Billion in 2023
During the forecast period 2023-2033, the medical biomimetics market is expected to grow at a value of 7% CAGR, according to Future Market Insights. By the year 2033, the global market for medical biomimetics is expected to rise up to a market valuation of US$ 63.15 Billion. Growing advancement in nanotechnology, increasing demand for prostheses and implant, …
Continue reading “Medical Biomimetics Market value of US$ 32.10 Billion in 2023”
Hand Eczema (HE) Treatment Market value of US$ 114.42 Million by registering a CAGR of 8% from 2023 to 2033
The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …
Medical Disposables Market Japan is expected to register a CAGR of nearly 5.7% from 2023 to 2033 | FMI Study
According to Future Market Insights’ recently published Medical Disposables industry analysis report, global sales of medical disposables were estimated to reach US$ 153.5 billion in 2022. The market is anticipated to reach a valuation of US$ 326.4 billion by 2033 with a CAGR of 7.1% from 2023 to 2033. The highest revenue-generating product category, bandages …
Nasal Polyposis Treatment Market to reach US$ 8.8 billion by 2033, Corticosteroids to Constitute 55% of all Treatments: FMI Report
in value terms by 2023-end and is projected to rise at a CAGR of 6.7% until 2033, according to a recently published report by Future Market Insights. By the end of the said forecast period, a valuation of US$ 8.8 billion is expected for the market. A growing geriatric population suffering from chronic rhinosinusitis, with …